Development
Biogen Inc.
BIIB
$138.60
$3.662.71%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.05B | 2.29B | 6.08B | 5.04B | 4.89B |
Total Receivables | 2.53B | 2.63B | 2.54B | 2.84B | 2.94B |
Inventory | 2.53B | 2.98B | 1.33B | 1.28B | 1.34B |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 752.00M | 551.80M | 480.70M | 602.10M | 618.80M |
Total Current Assets | 6.86B | 8.45B | 10.43B | 9.76B | 9.79B |
|
|||||
Total Current Assets | 6.86B | 8.45B | 10.43B | 9.76B | 9.79B |
Net Property, Plant & Equipment | 3.73B | 3.76B | 3.67B | 3.70B | 3.70B |
Long-term Investments | 6.22B | 6.81B | 5.75B | 5.75B | 5.75B |
Goodwill | 6.22B | 6.81B | 5.75B | 5.75B | 5.75B |
Total Other Intangibles | 8.36B | 7.34B | 1.78B | 1.81B | 1.85B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.05B | 1.17B | 1.32B | 1.70B | 1.69B |
Total Assets | 26.84B | 28.19B | 25.16B | 24.60B | 24.55B |
|
|||||
Total Accounts Payable | 403.30M | 440.10M | 445.40M | 491.20M | 491.50M |
Total Accrued Expenses | 1.45B | 1.42B | 1.42B | 1.28B | 1.50B |
Short-term Debt | 150.00M | 500.00M | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 90.30M | -- | -- | -- | 97.20M |
Total Finance Division Other Current Liabilities | 1.34B | 2.66B | 1.32B | 1.25B | 1.19B |
Total Other Current Liabilities | 1.34B | 2.66B | 1.32B | 1.25B | 1.19B |
Total Current Liabilities | 3.43B | 5.02B | 3.19B | 3.01B | 3.27B |
|
|||||
Total Current Liabilities | 3.43B | 5.02B | 3.19B | 3.01B | 3.27B |
Long-Term Debt | 6.79B | 6.79B | 6.28B | 6.28B | 6.28B |
Short-term Debt | 150.00M | 500.00M | -- | -- | -- |
Capital Leases | 400.00M | 428.80M | 304.40M | 327.00M | 333.00M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.42B | 1.48B | 920.80M | 1.19B | 1.28B |
Total Liabilities | 12.05B | 13.71B | 10.70B | 10.81B | 11.17B |
|
|||||
Common Stock & APIC | 302.60M | 242.30M | 170.80M | 91.30M | 73.40M |
Retained Earnings | 17.63B | 17.38B | 17.45B | 16.85B | 16.47B |
Treasury Stock & Other | -3.13B | -3.14B | -3.15B | -3.15B | -3.14B |
Total Common Equity | 14.80B | 14.48B | 14.47B | 13.80B | 13.40B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 14.80B | 14.48B | 14.47B | 13.80B | 13.40B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -4.10M | -6.40M | -9.60M | -9.50M |
Total Equity | 14.80B | 14.48B | 14.46B | 13.79B | 13.39B |
|